Arecor Therapeutics plc (AIM:AREC)
London flag London · Delayed Price · Currency is GBP · Price in GBX
77.50
-6.50 (-7.74%)
Oct 7, 2025, 3:16 PM GMT+1

Arecor Therapeutics Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
5.065.054.572.41.161.7
Upgrade
Revenue Growth (YoY)
3.31%10.50%90.30%107.51%-31.80%-10.21%
Upgrade
Cost of Revenue
3.463.513.32---
Upgrade
Gross Profit
1.61.541.252.41.161.7
Upgrade
Selling, General & Admin
4.876.186.175.382.391.64
Upgrade
Research & Development
2.63.045.48.615.393.94
Upgrade
Other Operating Expenses
-0.32-0.27-1.14-1.25-0.64-0.45
Upgrade
Operating Expenses
7.158.9510.4312.747.145.13
Upgrade
Operating Income
-5.55-7.41-9.18-10.34-5.98-3.43
Upgrade
Interest Expense
-0.02-0.02-0.02-0.02-0.02-0.08
Upgrade
Interest & Investment Income
0.070.10.280.1100
Upgrade
Other Non Operating Income (Expenses)
--0.01---0.01
Upgrade
EBT Excluding Unusual Items
-5.49-7.33-8.9-10.25-6-3.51
Upgrade
Merger & Restructuring Charges
----0.17--
Upgrade
Impairment of Goodwill
-1.48-1.48----
Upgrade
Asset Writedown
-1.8-1.8----
Upgrade
Other Unusual Items
-----0.95-
Upgrade
Pretax Income
-8.37-10.62-8.9-10.42-6.95-3.51
Upgrade
Income Tax Expense
-0.27-0.38-0.35-1.16-0.78-0.76
Upgrade
Net Income
-8.1-10.24-8.55-9.26-6.17-2.75
Upgrade
Net Income to Common
-8.1-10.24-8.55-9.26-6.17-2.75
Upgrade
Shares Outstanding (Basic)
373331292316
Upgrade
Shares Outstanding (Diluted)
373331292316
Upgrade
Shares Change (YoY)
20.82%9.20%5.83%25.63%41.77%3.04%
Upgrade
EPS (Basic)
-0.22-0.31-0.28-0.32-0.27-0.17
Upgrade
EPS (Diluted)
-0.22-0.31-0.28-0.32-0.27-0.17
Upgrade
Free Cash Flow
-6.22-9.18-5.99-11.08-5.52-1.91
Upgrade
Free Cash Flow Per Share
-0.17-0.27-0.20-0.38-0.24-0.12
Upgrade
Gross Margin
31.67%30.54%27.36%100.00%100.00%100.00%
Upgrade
Operating Margin
-109.56%-146.63%-200.63%-430.34%-516.15%-201.88%
Upgrade
Profit Margin
-160.13%-202.57%-187.05%-385.35%-532.73%-162.07%
Upgrade
Free Cash Flow Margin
-122.96%-181.63%-131.03%-461.05%-476.60%-112.43%
Upgrade
EBITDA
-5.35-7.1-8.88-10.14-5.9-3.34
Upgrade
EBITDA Margin
-105.65%-140.47%-194.18%---196.70%
Upgrade
D&A For EBITDA
0.20.310.30.20.080.09
Upgrade
EBIT
-5.55-7.41-9.18-10.34-5.98-3.43
Upgrade
EBIT Margin
-109.56%-146.63%-200.63%---201.88%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.